Cover Image


View/Hide Left Panel

Manson, J.E., and Bassuk, S.S. (2007). Menopausal hormone therapy and the risk of coronary heart disease. Does the relation vary by age or time since menopause? Monitor, 17-22.

Manson, J.E., Bassuk, S.S., Mitchell Harman, S., Brinton, E.A., Cedars, M.I., Lobo, R., Merriam, G.R., Miller, V.M., Naftolin, F., and Santoro, N. (2006). Postmenopausal hormone therapy: New questions and the case for new clinical trials. Menopause: Journal of the North American Menopause Society, 13, 139-147.

Manson, J.E., Allison, M.A., Rossouw, J.E., Carr, J.J., Langer, R.D., Hsia, J., Kuller, L.H., Cochrane, B.B., Hunt, J.R., Ludlam, S.E., Pettinger, M.B., Gass, M., Margolis, K.L., Nathan, L., Ockene, J.K., Prentice, R.L., Robbins, J., Stefanick, M.L., and the WHI and WHI-CACS investigators. (2007). Estrogen therapy and coronary-artery calcification. New England Journal of Medicine, 356, 2591-2602.

Meslé, F., and Vallin, J. (2006). Diverging trends in female old-age mortality: The United States and the Netherlands versus France and Japan. Population and Development Review, 32(1), 123-145.

Million Women Study Collaborators. (2002). Patterns of use of hormone replacement therapy in one million women in Britain, 1996-2000. BJOG: International Journal of Obstetrics and Gynaecology, 109, 1319-1330.

Nagata, C., Matsushita, Y., and Shimizu, H. (1996). Prevalence of hormone replacement therapy and user’s characteristics: A community survey in Japan. Maturitas, 25(3), 201-207.

Nelson, H.D., Humphrey, L.L., Nygren, P., Teutsch, S.M., and Allan, J.D. (2002). Postmenopausal hormone replacement therapy: Scientific review. Journal of the American Medical Association, 288, 872-881.

Prentice, R.L., and Anderson, G.L. (2008). The Women’s Health Initiative: Lessons learned. Annual Review of Public Health, 29, 131-150.

Prentice, R.L., Manson, J.E., Langer, R.D., Anderson, G.L., Pettinger, M., Jackson, R.D., Johnson, K.C., Kuller, L.J., Lane, D.S., Wactawski-Wende, J., Brzyski, R., Allison, M., Ockene, J., Sarto, G., and Rossouw, J.E. (2009). Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause. American Journal of Epidemiology, 170(1), 12-23.

Ravdin, P.M., Cronin, K.A., Howlader, N., Berg, C.D., Chlebowski, R.T., Feuer, E.J., Edwards, B.K., and Berry, D.A. (2007). The decrease in breast-cancer incidence in 2003 in the United States. New England Journal of Medicine, 356(16), 1670-1674.

Ringa, V., and Fournier, A. (2008). Did the decrease in use of menopausal hormone therapy induce a decrease in the incidence of breast cancer in France (and elsewhere)? Revue d’Épidémiologie et de Santé Publique, 56, e8-e12.

Rossouw, J.E., Prentice, R.L., Manson, J.E., Wu, L., Barad, D., Barnabei, V.M., Ko, M., LaCroix, A.Z., Margolis, K.L., and Stefanick, M.L. (2007). Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. Journal of the American Medical Association, 297, 1465-1477.

Salpeter, S.R., Walsh, J.M.E., Greyber, E., Ormiston, T.M., and Salpeter, E.E. (2004). Mortality associated with hormone replacement therapy in younger and older women. Journal of General Internal Medicine, 19, 791-804.

Salpeter, S.R., Walsh, J.M.E., Greyber, E., and Salpeter, E.E. (2006). Brief report: Coronary heart disease events associated with hormone therapy in younger and older women. Journal of General Internal Medicine, 21, 363-366.

Scarabin, P., Oger, E., and Plu-Bureau, G. (2003). Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk. Lancet, 362, 428-432.

Schneider, H.P.G. (2002). Report on the 10th World Congress on Menopause. June 2002, Berlin, Germany. Climacteric, 5, 219-228.

Stevenson, J.C. (2009). Type and route of estrogen administration. Climacteric, 12, 86-90.

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement